Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2024 年第 2 季持倉
持倉截至 2024/6/30，2024/8/14 申報。只含多頭部位，變化是跟 2024 年第 1 季比股數。
- 持股檔數
- 85
- 較 2024 年第 1 季 −2
- 總值
- $23.5 億
- 較 2024 年第 1 季 −$4.60 億 (−16.4%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ISRGIntuitive Surgical Inc | COM NEW | 245,000 | $1.09 億 | 4.6% | +19,000+8.4% | 加碼 | 歷史 |
| BSXBoston Scientific Corp | Stock | 1,170,100 | $9,011 萬 | 3.8% | −785,900−40.2% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 766,500 | $8,300 萬 | 3.5% | −36,800−4.6% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 2,987,845 | $7,954 萬 | 3.4% | +2,655+0.1% | 加碼 | 歷史 |
| ACHCAcadia Healthcare Company, Inc. | COM | 1,120,000 | $7,564 萬 | 3.2% | +115,000+11.4% | 加碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 2,917,231 | $7,550 萬 | 3.2% | +199,677+7.3% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 3,335,000 | $6,847 萬 | 2.9% | +922,500+38.2% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 491,000 | $6,760 萬 | 2.9% | −45,500−8.5% | 減碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 3,086,000 | $6,542 萬 | 2.8% | +391,000+14.5% | 加碼 | 歷史 |
| CICigna Group | Stock | 184,500 | $6,099 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 544,500 | $5,811 萬 | 2.5% | −39,500−6.8% | 減碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 222,000 | $5,395 萬 | 2.3% | −21,000−8.6% | 減碼 | 歷史 |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 48,000 | $5,045 萬 | 2.1% | −20,000−29.4% | 減碼 | 歷史 |
| ILMNIllumina, Inc. | COM | 478,000 | $4,989 萬 | 2.1% | +13,900+3.0% | 加碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 372,000 | $4,949 萬 | 2.1% | −229,000−38.1% | 減碼 | 歷史 |
| ABBVAbbVie Inc. | Stock | 277,800 | $4,765 萬 | 2.0% | +50,800+22.4% | 加碼 | 歷史 |
| TMOThermo Fisher Scientific Inc. | Stock | 80,000 | $4,424 萬 | 1.9% | +43,400+118.6% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,075,000 | $4,222 萬 | 1.8% | +211,000+24.4% | 加碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 383,000 | $4,128 萬 | 1.8% | −43,000−10.1% | 減碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 1,296,225 | $4,092 萬 | 1.7% | −158,540−10.9% | 減碼 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 325,000 | $4,024 萬 | 1.7% | −177,000−35.3% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 960,000 | $3,946 萬 | 1.7% | +26,500+2.8% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,117,000 | $3,922 萬 | 1.7% | +317,300+39.7% | 加碼 | 歷史 |
| DHRDanaher Corp | Stock | 150,000 | $3,748 萬 | 1.6% | +6,200+4.3% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 840,219 | $3,520 萬 | 1.5% | +455,974+118.7% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 110,000 | $3,504 萬 | 1.5% | −107,000−49.3% | 減碼 | 歷史 |
| INCYIncyte Corp | COM | 529,000 | $3,207 萬 | 1.4% | +529,000 | 新進 | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 1,306,477 | $3,108 萬 | 1.3% | −138,523−9.6% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 3,037,668 | $3,029 萬 | 1.3% | +3,037,668 | 新進 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 376,000 | $3,027 萬 | 1.3% | −55,000−12.8% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 754,000 | $2,940 萬 | 1.2% | +44,000+6.2% | 加碼 | 歷史 |
| DXCMDexcom Inc | COM | 259,000 | $2,937 萬 | 1.2% | +82,100+46.4% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 755,000 | $2,930 萬 | 1.2% | +120,000+18.9% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 430,000 | $2,881 萬 | 1.2% | +430,000 | 新進 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 400,000 | $2,740 萬 | 1.2% | −200,000−33.3% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 1,559,826 | $2,720 萬 | 1.2% | +1,559,826 | 新進 | 歷史 |
| GKOSGLAUKOS Corp | COM | 224,000 | $2,651 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| NGNENeurogene Inc. | COM | 727,537 | $2,648 萬 | 1.1% | +262,300+56.4% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 60,500 | $2,602 萬 | 1.1% | +60,500 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 731,104 | $2,500 萬 | 1.1% | −411,746−36.0% | 減碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 531,000 | $2,413 萬 | 1.0% | +306,000+136.0% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 908,000 | $2,397 萬 | 1.0% | +403,000+79.8% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,100,000 | $2,368 萬 | 1.0% | +75,000+7.3% | 加碼 | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 290,000 | $2,328 萬 | 1.0% | −190,000−39.6% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 284,000 | $2,144 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 487,000 | $1,916 萬 | 0.8% | +102,107+26.5% | 加碼 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM NEW | 782,000 | $1,775 萬 | 0.8% | +22,000+2.9% | 加碼 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 1,800,000 | $1,769 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 398,000 | $1,763 萬 | 0.7% | −270,300−40.4% | 減碼 | 歷史 |
| GILDGilead Sciences, Inc. | Stock | 255,000 | $1,750 萬 | 0.7% | +255,000 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,620,000 | $1,669 萬 | 0.7% | −115,000−6.6% | 減碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 205,000 | $1,599 萬 | 0.7% | +45,000+28.1% | 加碼 | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 343,200 | $1,568 萬 | 0.7% | +133,500+63.7% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 450,000 | $1,562 萬 | 0.7% | +375,000+500.0% | 加碼 | 歷史 |
| SNYSanofi | SPONSORED ADR | 315,000 | $1,528 萬 | 0.6% | +315,000 | 新進 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 1,300,064 | $1,521 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $1,488 萬 | 0.6% | +7,419,355 | 新進 | 歷史 |
| EXASExact Sciences Corp | COM | 338,500 | $1,430 萬 | 0.6% | +338,500 | 新進 | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 764,200 | $1,328 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 559,300 | $1,074 萬 | 0.5% | +84,300+17.7% | 加碼 | 歷史 |
| IMNMImmunome Inc. | COM | 873,891 | $1,057 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 8,902,972 | $988.2 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 215,600 | $975.6 萬 | 0.4% | +215,600 | 新進 | 歷史 |
| Cybin Ord23256X100 | COM | 34,884,000 | $945.4 萬 | 0.4% | 00.0% | 不變 | – |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,673,538 | $863.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,000,706 | $843.6 萬 | 0.4% | +555,000+124.5% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $677.8 萬 | 0.3% | −86,400−30.2% | 減碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 373,000 | $596.4 萬 | 0.3% | +373,000 | 新進 | 歷史 |
| PATHUiPath, Inc. | Stock | 362,000 | $459.0 萬 | 0.2% | +362,000 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 195,000 | $458.4 萬 | 0.2% | +195,000 | 新進 | 歷史 |
| IMTXImmatics N.V. | SHS | 393,100 | $456.8 萬 | 0.2% | +393,100 | 新進 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 93,000 | $443.2 萬 | 0.2% | −37,000−28.5% | 減碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 1,000,000 | $383.0 萬 | 0.2% | +1,000,000 | 新進 | 歷史 |
| EDITEditas Medicine, Inc. | COM | 816,000 | $381.1 萬 | 0.2% | +816,000 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 170,000 | $380.5 萬 | 0.2% | +170,000 | 新進 | 歷史 |
| COLLCollegium Pharmaceutical, Inc | COM | 117,000 | $376.7 萬 | 0.2% | −244,400−67.6% | 減碼 | 歷史 |
| PRMEPrime Medicine, Inc. | COM | 694,000 | $356.7 萬 | 0.2% | −1,296,000−65.1% | 減碼 | 歷史 |
| ACIUAC Immune SA | SHS | 825,000 | $329.2 萬 | 0.1% | −3,645,000−81.5% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 5,026,000 | $301.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,448,728 | $289.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 2,018,500 | $175.1 萬 | 0.1% | −6,280,070−75.7% | 減碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 350,000 | $174.7 萬 | 0.1% | +350,000 | 新進 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,188,178 | $101.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CMAXCareMax, Inc. | COMM STK | 21,200 | $5.91 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 12,136 | $1,942 | <0.1% | −77,407−86.4% | 減碼 | – |
2024 年第 1 季之後清倉（20 檔）
2024 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 1 季股數 | 2024 年第 1 季市值 | 2024 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| FUSNFusion Pharmaceuticals Inc. | COM | 6,500,328 | $1.39 億 | 4.9% | 歷史 |
| ALGNAlign Technology Inc | COM | 189,000 | $6,198 萬 | 2.2% | 歷史 |
| LLYEli Lilly & Co | Stock | 70,000 | $5,446 萬 | 1.9% | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,174,700 | $4,657 萬 | 1.7% | 歷史 |
| CVSCVS Health Corp | Stock | 545,000 | $4,347 萬 | 1.5% | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 5,785,352 | $2,974 萬 | 1.1% | 歷史 |
| MCKMcKesson Corp | Stock | 33,300 | $1,788 萬 | 0.6% | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 383,500 | $1,654 萬 | 0.6% | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 982,000 | $1,382 萬 | 0.5% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 166,000 | $1,164 萬 | 0.4% | 歷史 |
| RDNTRadNet, Inc. | COM | 238,000 | $1,158 萬 | 0.4% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 588,500 | $1,088 萬 | 0.4% | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 1,221,555 | $510.6 萬 | 0.2% | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 202,333 | $502.6 萬 | 0.2% | 歷史 |
| EBSEmergent BioSolutions Inc. | COM | 1,908,000 | $482.7 萬 | 0.2% | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 1,150,000 | $373.8 萬 | 0.1% | 歷史 |
| DNAGinkgo Bioworks Holdings, Inc. | CL A SHS | 3,000,000 | $348.0 萬 | 0.1% | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 2,413,000 | $335.4 萬 | 0.1% | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 675,000 | $253.1 萬 | 0.1% | 歷史 |
| KODKodiak Sciences Inc. | COM | 300,000 | $157.8 萬 | 0.1% | 歷史 |